Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
There is a dearth of epidemiological data about multiple sclerosis (MS) and related demyelinating disorders in India. In this study, a registry method was used for collecting data from secure sources and the index cases were verified Seventy nine patients were identified . A crude prevalence of 8.3/100,000 was obtained for MS and 6.2/100,000 for clinically-isolated syndrome (CIS). Age-standardized prevalence of MS relative to the world population was 7.8/100,000. Neuromyelitis optica (NMO) and spectrum disorders (NMOS) constituted 13.9% of all demyelinating disorders, with a prevalence of 2.6/100,000. Larger studies with more refined survey methodologies are required to understand the true prevalence of demyelinating disorders in India.
KS Hegde Medical Academy, Nitte University, Mangalore, India panditmng@gmail.com.
Lekha
L
Pandit
KS Hegde Medical Academy, Nitte University, Mangalore, India.
Rashmi
R
Kundapur
D000328:Adult; D017677:Age Distribution; D003625:Data Collection; D020278:Demyelinating Autoimmune Diseases, CNS / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012042:Registries
Clinically isolated syndrome; India; demyelinating disorders; epidemiology; multiple sclerosis; neuromyelitis optica; prevalence; registry